Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data, Maple Leaf to Co-Develop SNP-Based Pork Traceability Tests

NEW YORK, May 8 (GenomeWeb News) - Clinical Data said today that it has signed an agreement with Canada's Maple Leaf Foods to co-develop and co-market a SNP-based pork traceability system.

 

Maple Leaf's porcine traceability system is intended to genetically trace back any pork product to its farm of origin by means of a SNP-based test.

 

Clinical Data's Cogenics division, a pharmacogenomic services provider, will conduct the work.

 

The DNA traceability system operates through parentage analysis based on blood samples collected at each farm where traceability is to be established. Each parental animal will have its DNA fingerprint recorded in a searchable database so that pork products can be traced back to their farm of origin by DNA tracing.

 

Cogenics will develop the fingerprinting panel based on a set of proprietary markers spread throughout the porcine genome, Clinical Data said.

 

Financial terms of the agreement were not provided.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.